These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33533166)

  • 1. Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies.
    Dijkshoorn ABC; van Stralen HE; Sloots M; Schagen SB; Visser-Meily JMA; Schepers VPM
    Psychooncology; 2021 May; 30(5):635-648. PubMed ID: 33533166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological Effects of Chemotherapy: Systematic Review of Longitudinal Studies on Objective Cognitive Impairment in Breast Cancer Patients.
    Kim HJ; Kim JEE; Jung SO; Lee D; Abraham I
    Cancer Nurs; 2023 May-Jun 01; 46(3):E159-E168. PubMed ID: 35324504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study.
    Schrauwen W; Van de Cavey J; Vingerhoets G; Vanheule S; Van den Broecke R; Denys H
    J Int Neuropsychol Soc; 2020 Sep; 26(8):806-814. PubMed ID: 32312360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
    Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
    J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a relationship between objectively measured cognitive changes in patients with solid tumours undergoing chemotherapy treatment and their health-related quality of life outcomes? A systematic review.
    Dwek MR; Rixon L; Hurt C; Simon A; Newman S
    Psychooncology; 2017 Oct; 26(10):1422-1432. PubMed ID: 27893174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
    Perrier J; Viard A; Levy C; Morel N; Allouache D; Noal S; Joly F; Eustache F; Giffard B
    Brain Imaging Behav; 2020 Feb; 14(1):226-241. PubMed ID: 30406352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study.
    Menning S; de Ruiter MB; Kieffer JM; Agelink van Rentergem J; Veltman DJ; Fruijtier A; Oldenburg HS; Boven E; van der Meij S; Lustig V; Bos ME; Boogerd W; Reneman L; Schagen SB
    J Pain Symptom Manage; 2016 Oct; 52(4):560-569.e1. PubMed ID: 27650011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer.
    Rodríguez Martín B; Fernández Rodríguez EJ; Rihuete Galve MI; Cruz Hernández JJ
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33265966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer.
    Noal S; Levy C; Hardouin A; Rieux C; Heutte N; Ségura C; Collet F; Allouache D; Switsers O; Delcambre C; Delozier T; Henry-Amar M; Joly F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):795-803. PubMed ID: 20888704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy.
    Cerulla Torrente N; Navarro Pastor JB; de la Osa Chaparro N
    J Cancer Surviv; 2020 Aug; 14(4):464-482. PubMed ID: 32146576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patients.
    Kim HJ; Jung SO; Kim H; Abraham I
    Psychooncology; 2020 Apr; 29(4):617-631. PubMed ID: 32017297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; van Dam FS; Schagen SB
    Psychooncology; 2010 Apr; 19(4):415-22. PubMed ID: 19514094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.
    Lange M; Heutte N; Noal S; Rigal O; Kurtz JE; Lévy C; Allouache D; Rieux C; Lefel J; Clarisse B; Leconte A; Veyret C; Barthélémy P; Longato N; Tron L; Castel H; Eustache F; Giffard B; Joly F
    Oncologist; 2019 Jan; 24(1):62-68. PubMed ID: 29934409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies.
    Sousa H; Almeida S; Bessa J; Pereira MG
    Neuropsychol Rev; 2020 Sep; 30(3):287-309. PubMed ID: 32607817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.